Conversion of substrate analogs suggests a Michael cyclization in iridoid 
biosynthesis

Lindner, Stephanie; Geu-Flores, Fernando; Braese, Stefan; Sherden, Nathaniel H.; O'Connor, Sarah E.

doi:10.1016/j.chembiol.2014.09.010

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Conversion of substrate analogs suggests a Michael cyclization in iridoid biosynthesis

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

https://www.sciencedirect.com/science/article/pii/S1074552114003287?via%3Dihub
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

SOC047.pdf
(Publisher version), 752KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Lindner, S., Geu-Flores, F., Braese, S., Sherden, N. H., & O'Connor, S. E. (2014). Conversion of substrate analogs suggests a Michael cyclization in iridoid biosynthesis. Chemistry & Biology, 21(11), 1452-1456. doi:10.1016/j.chembiol.2014.09.010.

Cite as: https://hdl.handle.net/21.11116/0000-0002-B589-7

Abstract

The core structure of the iridoid monoterpenes is formed by a unique cyclization reaction. The enzyme that catalyzes this reaction, iridoid synthase, is mechanistically distinct from other terpene cyclases. Here we describe the synthesis of two substrate analogs to probe the mechanism of iridoid synthase. Enzymatic assay of these substrate analogs along with clues from the product profile of the native substrate strongly suggest that iridoid synthase utilizes a Michael reaction to achieve cyclization. This improved mechanistic understanding will facilitate the exploitation of the potential of iridoid synthase to synthesize new cyclic compounds from nonnatural substrates.